ArticleJournal of experimental & clinical cancer research : CR2025
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors.
Daniela Esposito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.